TWN Info Service on Health Issues (2016)

• No scientific rationale for lifting of FDC ban
  (06 Dec 16)
• WHO: Member State Mechanism agrees to drop "counterfeit" term
  by TWN (30 Nov 16)
• 237 deaths by Pentavalent vaccine and still counting
  (25 Nov 16)
• Zika's million-dollar question: Where are the birth defects?
  (22 Nov 16)
• Health: WHO D-G warns of serious funding shortfalls in 2016-17 budget
  by Kanaga Raja (04 Nov 16)
• Shining a spotlight on the 2030 Agenda
  by Kanaga Raja (01 Nov 16)
• Coke and Pepsi Give Millions to Public Health, Then Lobby Against It
  by Anahad O’Connor (19 Oct 16)
• CSOs say NO to 'TRIPS Plus' in regional trade agreement
  (17 Oct 16)
• GPW Briefing #13 - UN and business community, out-sourcing or crowding in?
  by Barbara Adams (11 Oct 16)
• SouthNews: UN Human Rights Council creates position of Special Rapporteur on the Right to Development
  by Adriano José Timossi (06 Oct 16)
• UN Political Declaration on Antimicrobial Resistance Signals High Level Recognition
  by Mirza Alas (27 Sept 16)
• World leaders pledge action to control superbugs
  by Martin Khor (27 Sept 16)
• Health and environment should be at the forefront
  by Martin Khor (13 Sept 16)
• The unfulfilled promises of innovation and expansion of IPRs
  by Kanaga Raja (05 Sept 16)
• UN: Menace of fraud deserves serious attention, says JIU report
  by Chakravarthi Raghavan (22 Jul 16)
• Uruguay: Wins dispute before ICSID over its tobacco control policies
  by Chakravarthi Raghavan (18 Jul 16)
• New - Spotlight Report on Sustainable Development
  (13 Jul 16)
• Access to medicines fundamental to achieving right to health
  by Kanaga Raja (04 Jul 16)
• AIDS meeting was bold but disappointing say organisations
  by Tharanga Yakupitiyage (29 Jun 16)
• Antibiotic resistance requires global response
  by Lyndal Rowlands (29 Jun 16)
• WHO: South rejected Secretariat's market-based proposal to address medicines shortage
  by K M Gopakumar (20 Jun 16)
• EU sharply criticised over new trademarks directive
  by Kanaga Raja (17 Jun 16)
• The curious case of generic Hep C drug sofosbuvir
  by Leena Menghaney (14 Jun 16)
• WHO Member States concerned over unaffordable prices of medicines
  by Mirza Alas & K M Gopakumar (11 Jun 16)
• CSO letter to countries negotiating RCEP
  (10 Jun 16)
• Civil Society Joint Statement on the Occasion of Prime Minister Narendra Modi’s Visit to US
  (07 Jun 16)
• Health: Plain packaging of tobacco products can save lives, says WHO
  by Kanaga Raja (06 Jun 16)
• Indian national IPR policy - A reality check
  by K M Gopakumar (06 Jun 16)
• Facing up to the world’s critical health crises
  by Martin Khor (06 Jun 16)
• WHO: Member States agree to postpone discussions on R&D treaty
  by K M Gopakumar (02 Jun 16)
• WHO: Health Assembly adopts framework for non-State actor engagement
  by K M Gopakumar (31 May 16)
• Countries reaffirm need for high-level commitment on antimicrobial resistance
  by Mirza Alas (30 May 16)
• Pharma-linked organisations involved in WHO Guideline drafting
  by K M Gopakumar (27 May 16)
• WHO: Do not approve a faulty FENSA at WHA, urge CSOs
  by Kanaga Raja (26 May 16)
• South calls for rules on non-state actors engagement in climate treaty processes
  by Hilary Chiew & Chee Yoke Ling (24 May 16)
• Dangerous Proposal for "Gain of Function" Modification of Smallpox Virus
  (22 May 16)
• The slow shipwreck of the World Health Organization?
  by German Velasquez & Mirza Alas (18 May 16)
• Super drug-resistant gene raises new health alarm
  by Martin Khor (10 May 16)
• WHO Member States to decide on legally binding R&D agreement
  by K M Gopakumar (02 May 16)
• Academics call for WHO R&D agreement discussion to advance
  by K M Gopakumar (29 Apr 16)
• WHO: Member States to finalise FENSA during May Assembly
  by K M Gopakumar (29 Apr 16)
• WHO: Switzerland refuses to join consensus on FENSA emergency exception
  by K M Gopakumar (27 Apr 16)
• WHO: Norway re-opens paragraph on due diligence and risk assessment of NSA
  by TWN (27 Apr 16)
• WHO: Member States agree to prohibit private sector secondments
  by K M Gopakumar (26 Apr 16)
• Civil society call to save WHO from undue influence of corporations and corporate linked entities
  (26 Apr 16)
• WHO: Final FENSA negotiations to focus on private sector engagement
  by K M Gopakumar (25 Apr 16)
• WHO – Norway proposal on emergency exception weakens FENSA rules
  by K M Gopakumar (25 Apr 16)
• New threat against affordable medicines in trade negotiations with India and ASEAN
  (21 Apr 16)
• WHO: Developed countries turning against non-State actor engagement framework
  by K M Gopakumar (21 Apr 16)
• Nothing Special (301) to report
  by K. M. Gopakumar (18 Apr 16)
• DNDi and Pharco to test affordable hepatitis C regimen with support of Malaysian and Thai governments
  (14 Apr 16)
• Genetic control is no answer to Zika (or dengue)
  by Payyalore Krishnaier Rajagopalan (08 Apr 16)
• US business launches campaign against UNHLP
  by D. Ravi Kanth (06 Apr 16)
• SDG indicators challenged by many UN member states
  by Bhumika Muchhala (24 Mar 16)
• 2030 Agenda and the SDGs: indicator framework, monitoring and reporting
  by Barbara Adams & Karen Judd (22 Mar 16)
• Zika, dengue, malaria and the deadly mosquito
  by Martin Khor (17 Mar 16)
• Sustainability goals to get action going
  by Martin Khor (03 Mar 16)
• EU's new ICS would bring ISDS back from the dead
  by Kanaga Raja (24 Feb 16)
• WHO Executive Board adopts work plan on next FENSA negotiations
  by TWN (10 Feb 16)
• WHO: Executive Board to decide on agenda of open-ended meeting on R&D financing and coordination
  by K. M. Gopakumar (28 Jan 16)
• WHO: Is the Secretariat’s proposal on medicines shortage a windfall for big pharma?
  by K. M. Gopakumar (28 Jan 16)
• China’s Patent Office Invalidated Novartis’ Patent on Gleevec
  (27 Jan 16)